Target Validation Information | |||||
---|---|---|---|---|---|
TTD ID | T75797 | ||||
Target Name | Prostaglandin F2-alpha receptor (PTGFR) | ||||
Type of Target |
Successful |
||||
Drug Potency against Target | Latanoprost | Drug Info | Ki = 98 nM | [3] | |
Travoprost | Drug Info | EC50 = 17.5~37 nM | [2] | ||
LAROPIPRANT | Drug Info | Ki = 9991 nM | [1] | ||
References | |||||
REF 1 | Discovery of a potent and selective prostaglandin D2 receptor antagonist, [(3R)-4-(4-chloro-benzyl)-7-fluoro-5-(methylsulfonyl)-1,2,3,4-tetrahydroc... J Med Chem. 2007 Feb 22;50(4):794-806. | ||||
REF 2 | Real-time intracellular Ca2+ mobilization by travoprost acid, bimatoprost, unoprostone, and other analogs via endogenous mouse, rat, and cloned human FP prostaglandin receptors. J Pharmacol Exp Ther. 2003 Jan;304(1):238-45. | ||||
REF 3 | Ocular hypotensive FP prostaglandin (PG) analogs: PG receptor subtype binding affinities and selectivities, and agonist potencies at FP and other PG receptors in cultured cells. J Ocul Pharmacol Ther. 2003 Dec;19(6):501-15. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.